Serodus ASA Share Price

Stocks

03/17/03	Serodus : Primary endpoint reached by SER150 Phase 2a study in Diabetic Nephropathy.	PU
08/16/08	Serodus : Q&A delisting from Oslo Axess	PU
23/16/23	Serodus : Extraordinary general meeting held	PU
23/16/23	Serodus : Viggo Harboe Holding 2006 ApS announces results of voluntary offer	PU
02/16/02	Serodus : Viggo Harboe Holding 2006 Aps Launces voluntary offer for outstanding shares in Serodus ASA – Acceptance period starting 31 October 2016	PU

1 day

-5.56%

Manager	Title	Age	Since
Arnstein Gunnestad Endresen CEO	Chief Executive Officer	73	01/01/2023
Henrik Mordhorst DFI	Director of Finance/CFO	-	01/10/2019
Daniel Capion PRN	Corporate Officer/Principal	-	01/01/2021

Director	Title	Age	Since
Terri Sebree BRD	Director/Board Member	68	01/04/2014
Viggo Gunnersen Harboe BRD	Director/Board Member	80	01/01/2022
Søren Elmann Ingerslev CHM	Chairman	-	01/01/2017

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SERODUS ASA	-5.56%	+7.94%	-	-	0
WUXI APPTEC CO., LTD.	-7.17%	-4.39%	+45.51%	+79.00%	5.21TCr
ARGENX SE	+0.24%	-1.54%	+52.85%	+71.85%	5.38TCr
INSMED INCORPORATED	+0.80%	-6.31%	+5.62%	+417.78%	2.35TCr
BIONTECH SE	-0.09%	-0.01%	-16.85%	-15.41%	2.31TCr
WUXI BIOLOGICS (CAYMAN) INC.	-5.95%	-2.58%	+29.53%	-9.47%	1.94TCr
GENMAB A/S	-1.14%	+0.03%	+31.67%	-30.65%	1.76TCr
PHARMAESSENTIA CORPORATION	-5.16%	-7.00%	+168.44%	+314.96%	1.52TCr
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-6.91%	-5.83%	+25.17%	+644.30%	1.48TCr
EXELIXIS, INC.	+0.43%	-1.03%	+25.75%	+189.74%	1.41TCr
Average	-3.05%	-2.62%	+40.85%	+184.68%	2.6TCr
Weighted average by Cap.	-2.80%	-2.36%	+40.17%	+144.40%

Employees

Sector